1st Quarter - Report

SPLITOAK STRATEGIES LLC for CARIS LIFE SCIENCES, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 2407/S 2085 The Medicare Multi-Cancer Early Detection Screening Coverage Act; Appropriate payment and coverage criteria for certain advanced diagnostic tests

LobbyistCovered position, as disclosed
SARAH KUEHL EGGE Legislative Assistant to Senator Bob Kerrey (1998-2000); Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (2001-2012); Deputy Staff Director\, Joint Select Committee on Deficit Reduction (Fall 2011)
AMY JENSEN Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2407 (118th)

Medical/Disease Research/Clinical Labs MED

Ensuring access to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; Use of real-world evidence in clinical trials and FDA review; Cancer Moonshot; FDA proposed regulation to provide oversight of diagnostic lab tests (FDA-2023-N-2177)

LobbyistCovered position, as disclosed
AMY JENSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Providing an appropriate regulatory model for advanced genomic cancer testing (FDA-2023-2177), Artificial Intelligence proposals

LobbyistCovered position, as disclosed
AMY JENSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.